Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Prevention of perinatal HIV transmission during pregnancy
Joseph P. McGowan
, Sanjiv S. Shah
Research output
:
Contribution to journal
›
Review article
›
peer-review
54
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Prevention of perinatal HIV transmission during pregnancy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
AIDS/HIV
100%
During Pregnancy
100%
Virus Transmission
100%
Antiretroviral Therapy
57%
Zidovudine
57%
Pregnant Women
42%
Viral Suppression
28%
Human Immunodeficiency Virus Type 1 (HIV-1)
14%
Recent Advances
14%
Disease Progression
14%
Monotherapy
14%
Human Immunodeficiency Virus Infection
14%
Long-term Efficacy
14%
Pharmacokinetics
14%
Antepartum
14%
Delivery Time
14%
Non-pregnant Women
14%
Vertical Transmission
14%
Virus Diseases
14%
Treatment Study
14%
Elective Caesarean Section
14%
Plasma Viral Load
14%
Mother-child
14%
Antiretroviral Agents
14%
Infections In Pregnancy
14%
After Delivery
14%
Infected Mother
14%
Antiretroviral Regimen
14%
Sustained Viral Suppression
14%
Resource-poor Countries
14%
Intrapartum
14%
Adverse Event Profiles
14%
Labor & Delivery
14%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Virus Transmission
100%
Zidovudine
57%
Antiretroviral Therapy
42%
Neonatal Infant
28%
Pregnant Woman
28%
Human Immunodeficiency Virus Infection
14%
Disease Exacerbation
14%
Monotherapy
14%
Human Immunodeficiency Virus 1
14%
Pharmacokinetics
14%
Virus Infection
14%
Cesarean Section
14%
Intrapartum
14%
Antiretrovirus Agent
14%
Vertical Transmission
14%
Adverse Event
14%
Nursing and Health Professions
Human Immunodeficiency Virus
100%
Virus Transmission
100%
Zidovudine
50%
Antiretroviral Therapy
37%
Human Immunodeficiency Virus Infection
12%
Adverse Event
12%
Disease Exacerbation
12%
Monotherapy
12%
Virus Load
12%
Cesarean Section
12%
Virus Infection
12%
Antiretrovirus Agent
12%
Vertical Transmission
12%
Efficacy
12%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Virus Transmission
100%
Zidovudine
57%
Human Immunodeficiency Virus Infection
14%
Adverse Event
14%
Disease Exacerbation
14%
Monotherapy
14%
Human Immunodeficiency Virus 1
14%
Virus Infection
14%
Antiretrovirus Agent
14%
Vertical Transmission
14%
Pharmacokinetics
14%